Glioma Signaling
Gliomas, developing in the brain from the transformed glial cells, are a very special kind of tumor, extremely refractory to conventional treatments. Therefore, for the development of new antitumor strategies, a better understanding of molecular mechanism
- PDF / 11,922,736 Bytes
- 311 Pages / 504.63 x 737.01 pts Page_size
- 117 Downloads / 212 Views
Jolanta Barańska Editor
Glioma Signaling Second Edition
Advances in Experimental Medicine and Biology Volume 1202
Series Editors Wim E. Crusio, CNRS University of Bordeaux UMR 5287, Institut de Neurosciences Cognitives et Intégratives d’Aquitaine, Pessac Cedex, France John D. Lambris, University of Pennsylvania, Philadelphia, PA, USA Heinfried H. Radeke, Institute of Pharmacology & Toxicology, Clinic of the Goethe Univ. Frankfurt Main, Frankfurt am Main, Hessen, Germany Nima Rezaei, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
More information about this series at http://www.springer.com/series/5584
Jolanta Barańska Editor
Glioma Signaling Second Edition
Editor Jolanta Barańska Biochemistry Nencki Institute of Experimental Biology Warsaw, Poland
ISSN 0065-2598 ISSN 2214-8019 (electronic) Advances in Experimental Medicine and Biology ISBN 978-3-030-30650-2 ISBN 978-3-030-30651-9 (eBook) https://doi.org/10.1007/978-3-030-30651-9 1st edition: © Springer Science+Business Media Dordrecht 2013 2nd edition: © Springer Nature Switzerland AG 2020 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, expressed or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Springer imprint is published by the registered company Springer Nature Switzerland AG. The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
Preface
Glioma Signaling is now in its second edition. The appreciated reception by libraries and researchers of the first edition of this book reflected the need for such a resource covering the wide spectrum of mechanisms responsible for glioma physiology and pathobiology. In the second edition of the book many chapters present new, updated material. The book also contains new chapters, absent in the first edition. This edition concentrates on recent advances in the understanding of the molecular mechanisms controlling regulation of glioma growth, prog
Data Loading...
